SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-010128
Filing Date
2016-05-09
Accepted
2016-05-09 17:01:18
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctix_10q.htm 10-Q 422694
2 CERTIFICATION ctix_ex311.htm EX-31.1 7683
3 CERTIFICATION ctix_ex312.htm EX-31.2 7795
4 CERTIFICATION ctix_ex321.htm EX-32.1 3249
5 CERTIFICATION ctix_ex322.htm EX-32.2 3235
  Complete submission text file 0001477932-16-010128.txt   2531078

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctix-20160331.xml EX-101.INS 475626
7 XBRL TAXONOMY EXTENSION SCHEMA ctix-20160331.xsd EX-101.SCH 39447
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctix-20160331_cal.xml EX-101.CAL 44477
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctix-20160331_def.xml EX-101.DEF 90827
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctix-20160331_lab.xml EX-101.LAB 204906
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctix-20160331_pre.xml EX-101.PRE 164403
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 161632510
SIC: 2834 Pharmaceutical Preparations